February 2, 2026

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating Growth in Biotechnology with a 3.39% Potential Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO) has emerged as a prominent player in the biotechnology sector, focusing on developing innovative treatments for serious metabolic diseases. With a market capitalization of $4.5..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating the Upside with a Potential 2.85% Gain

Avidity Biosciences, Inc. (NASDAQ: RNA) stands at the forefront of a revolutionary approach in biotechnology, leveraging its proprietary antibody oligonucleotide conjugates (AOCs) platform to address previously untreatable diseases. As a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Uncovering a 38% Potential Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is gaining attention from investors with its promising potential upside of 38.09%. This commercial-stage biopharmaceutical company, headquartered in Boston, is pioneering treatments for rare neuroendocrine..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL) stands at a pivotal juncture in the healthcare sector, offering a fascinating blend of opportunity and challenge for investors. With a market capitalization..

Bausch + Lomb Corporation (BLCO): Investor Outlook on Eye Health Giant with a 5% Upside

Bausch + Lomb Corporation (BLCO), a renowned name in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling investment opportunity with a potential upside of..

BrightSpring Health Services, I (BTSG) Stock Analysis: A Promising 12.38% Upside in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands as a formidable player within the U.S. healthcare sector, specifically in the realm of Health Information Services. Operating primarily through its Pharmacy Solutions and..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring the 52.42% Potential Upside and Strategic Positioning in Biotechnology

TG Therapeutics, Inc. (NASDAQ: TGTX) has become a notable player in the biotechnology sector, capturing investor attention with its promising portfolio of treatments for B-cell mediated diseases. As a commercial-stage..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal Investment Potential

Cardinal Health, Inc. (NYSE: CAH) has positioned itself as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of $51.05 billion,..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Evaluating the 19.27% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is a clinical-stage biotechnology company making significant strides in the healthcare sector by focusing on precision oncology. Headquartered in Redwood City, California, Revolution Medicines is..

HealthEquity, Inc. (HQY) Investor Outlook: Unpacking a 39% Potential Upside

As the leading provider of health savings accounts (HSAs) and other consumer-directed benefits, HealthEquity, Inc. (NASDAQ: HQY) is capturing significant attention in the healthcare sector. With its innovative technology platforms..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 24.72% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector, and for good reason. With a strong focus on diagnostic and therapeutic products, the company has carved a..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking the 9.22% Potential Upside Amidst Mixed Performance Metrics

Bio-Techne Corporation (NASDAQ: TECH) stands as a notable player in the biotechnology sector, with a robust presence in the healthcare industry. Valued at a market capitalization of $9.99 billion, this..

GSK plc (GSK) Stock Analysis: Navigating Market Leadership with Robust Dividend Yield and Strategic Collaborations

GSK plc (NYSE: GSK), a stalwart in the global healthcare landscape, is showing promising indicators for investors seeking a blend of stable income and potential growth. With a market capitalization..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with Strategic Growth

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with its expansive product portfolio and strategic market positioning...

Biogen Inc. (BIIB) Stock Analysis: Navigating Healthcare with Strategic Collaborations and a 7.29% Upside

Biogen Inc. (BIIB), a prominent player in the healthcare sector, continues to be a compelling focus for investors who are keen on the pharmaceutical industry’s potential for innovation and growth...

Prestige Consumer Healthcare (PBH) Stock Analysis: Strong Buy Ratings Signal Nearly 20% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a prominent player in the healthcare sector, specifically within the drug manufacturers’ niche focusing on specialty and generic products. With a market capitalization..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Navigating a Promising Biotech Landscape with a Strong Buy Consensus

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the biotechnology sector, with a market capitalization of $8.1 billion. This Pittsburgh-based company has positioned itself as a frontrunner in genetic..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Powerhouse with 30.88% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leading player in the healthcare diagnostics and research industry, stands as a compelling investment opportunity for those looking to capitalize on the burgeoning demand for..

Zimmer Biomet Holdings (ZBH) Stock Analysis: Potential 18% Upside in a Competitive Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $17.26 billion, this Indiana-based..

West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 49.58% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a current market capitalization of $16.63..

Search

Funds

February 2, 2026

Search

Funds

February 2, 2026

FTSE 100

Funds